Notably, the ApoE-ε4 allele has been identified as a significant risk factor for conditions such as Alzheimer’s disease (AD) [2, 3] and multiple sclerosis (MS) [4], with a dose-dependent effect on both the risk and age of onset. Here, APOE is linked to multiple sclerosis.